Sign Up for a Free Account

Raphael Schiffmann MD

Director, Institute of Metabolic Disease

Baylor Scott & White Research Institute

Adjunct Professor, Baylor University

Contributor Disclosures

Dr. Schiffmann of Baylor Scott & White Research Institute received research grants from Amicus Therapeutics, Takeda Pharmaceutical Company, Protalix Biotherapeutics, and Sanofi Genzyme.